BioSpace News Archive

Sareum Holdings plc is pleased to announce the appointments of Michael Owen, PhD and Clive Birch as Non-Executive Directors.

GeoVax Continues Expansion of International Collaborative Efforts for its Unique MVA-VLP Vaccine Technology

AG10 Was Well Tolerated in Subjects Administered 400 mg or 800 mg Twice Daily for 28 Days

IBBL (Integrated BioBank of Luxembourg) celebrates this quarter the 10th anniversary of its creation.

Medical imaging manufacturer Planmed and med tech startup Disior are bringing next-generation medical image analysis software into clinical use. “Until today, 3D medical images have been analyzed using 2D slices, as if you were looking at the image with one eye only,” says professor and orthopedic surgeon Jari Salo.

Ultragenyx Pharmaceutical Inc. today announced that it has completed a pre-NDA meeting with the U.S. Food and Drug Administration (FDA) and plans to submit a New Drug Application (NDA) to the FDA for UX007 for the treatment of patients with long-chain fatty acid oxidation disorders (LC-FAOD) in mid-2019.

The report, which was issued by the Council of Economic Advisors, pointed to changes in the approval process at the FDA in the approval process of generic drugs has led to greater competition in the marketplace, which has lowered the costs of the medications.

Biomimicry, looking at how things are done in nature and applying that to solve problems, is utilized by many researchers. BioSpace looks at some examples of how scientists are performing cutting-edge research using biomimicry.

Medigene AG today reported financial results for the first 9 months of 2018 and provided a review of recent accomplishments and anticipated upcoming milestones.

Findings support development of γδ T cells for gastrointestinal diseases